囊性纤维化及其对肺栓塞预后的影响
Karsten Keller1, Volker H Schmitt2, Visvakanth Sivanathan3
1Department of Cardiology, University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany; Center for Thrombosis and Hemostasis (CTH), University Medical Center Mainz (Johannes Gutenberg-University Mainz), Mainz, Germany.
Thrombosis research
|September 26, 2025
概括
囊性纤维化 (CF) 肺栓塞 (PE) 患者年轻,并有更多的并发症. 在PE患者中,CF显著增加死亡,肺炎和出血的风险.
科学领域:
- 心血管医学 心血管医学
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 肺栓塞 (PE) 和囊性纤维化 (CF) 是不同的心血管-肺部疾病.
- 肌痛性肌痛是一种罕见的遗传性疾病,影响多个系统,减少预期寿命.
- 勃起前列腺是一个常见的,危及生命的紧急情况.
研究的目的:
- 研究囊性纤维化 (CF) 对肺栓塞 (PE) 患者预后的影响.
主要方法:
- 使用了德国全国性住院患者样本 (2005-2020年).
- 包括所有患有肺栓塞 (PE) 的病例.
- 基于囊性纤维化 (CF) 的存在或不存在而分层的PE患者.
主要成果:
- 分析了1,373,084例PE病例;126个 (0.01%) 患有CF.
- 患有CF的PE患者更年轻,并具有较低的并发症负担,但糖尿病发病率较高.
- 经调整后,CF与明显更高的病例死亡率 (OR 2.45),肺炎 (OR 1.52) 和需要输血 (OR 3.70) 相关.
结论:
- 患有CF的PE患者在较年轻时出现,并表现出不同的并发症,如糖尿病.
- 囊性纤维化与肺炎,出血事件的增加率,以及PE患者的病例死亡率增加2.5倍有关.
更多相关视频
相关概念视频
Cystic Fibrosis: Management
476
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
476
Cystic Fibrosis: Pathogenesis
722
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
722
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
328
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
328
Pulmonary Embolism III: Nursing Management
363
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
363
Pulmonary Embolism I: Introduction
516
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
516
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K


